covering development, operations and launch of digital health solutions
User-focused and proven user experience
Quality management as per ISO 13485
FDA & MDR
Fulfillment of all regulatory requirements for FDA & MDR
Regulatory grade collection
Regulatory grade collection of patient-generated data as clinical endpoints
standardized & validated
Battery of standardized & validated digital biomarkers for multiple indications
Innovative, digital solutions that put the patient at the center
For personalized patient support, we develop digital companions that are indication-specific and tailored to the individual needs of each patient. Our digital companions cover a wide variety of scopes: starting in the context of clinical studies, through therapy support, to stand-alone digital therapeutics. They comply with all international standards in terms of quality management and regulatory requirements (esp. MDR, FDA and ISO 13485).
Digital Patient Companions
Our digital patient companions are cutting-edge apps that support the patient along their journey through the healthcare system, acknowledging the unique and individual needs of each user. They encourage users to take their health into their own hands and help patients to adhere to their therapeutic plan. Our patient companions facilitate the continuous contact between health provider and their patients. Health care professionals (HCPs) obtain longitudinal, real-world insights into the individual patient’s condition.
Digital Trial Companions
Our digital trial companions support clinical studies by facilitating modern data collection. They provide longitudinal patient-reported outcomes of different types with high temporal resolution. Our study-specific “companion in the patient’s pocket” is easy-to-use with a motivating user interface and improves overall study compliance and adherence.
Digital Therapeutics (DTx)
Our end-to-end solution includes the development, launch and continuous operation of scalable digital therapeutics. They meet all quality management and regulatory requirements (MDR, FDA, etc.) and are therefore ideally suited for international use. Our digital therapeutics are DVG compliant and therefore meet the German reimbursement scheme for digital health applications (German: DiGAs). We have many years of experience and cooperate with a large number of health insurance companies to offer reimbursable digital therapeutics.
Temedica’s App Platform
Our app-platform technology has an excellent track record across many different application areas with various pharma and medtech partners. Our platform is the basis for the agile and replicable development of new digital companions, which of course meet all MDR and FDA requirements. We offer customers tailored solutions and deliver measurable results to gain unique insights into real-world data.
Hundreds of thousands of patients use our digital patient companions
Temedica offers patient-centric digital companion apps for an ever-growing number of indications. These mobile apps accompany patients on their health journey and support them with personalized, therapy-supporting guidance.
In Temedica, we have a dynamic, agile and inspirational partner, who helps us to move forward faster in our digital transformation and to unlock the potential of the digital world.
Temedica’s own brand product pelvina is a digital course to help strengthen the female pelvic floor. The effectiveness of pelvina has been proven in clinical studies and, with hundreds of thousands of users, pelvina is the market leader in Europe.
pelvina is reimbursable in all statutory health insurances in Germany.
The smartest solution for sustainable female health, pelvina daily is a easy and convenient solution for women to strengthen their pelvic floor and improve their overall wellbeing.
In Temedica, we have a competent and professional partner who will work together with us to further develop and drive forward the topic of digital patient support with the aim of achieving sustainable behavioral change. Temedica's digital competence, speed and creative start-up mentality are a valuable addition to our long-standing expertise and presence in the market.
Thanks to Temedica, we have found a regulatory compliant way to close the gap to our patients. The collaboration over several years has not only resulted in a great digital patient solution for us, but also in many valuable insights about digitization in the industry!
Waya helps overweight people to manage their weight sustainably. Users learn how to integrate healthy nutrition and physical exercise programs into their everyday lives.
Brisa is a companion for people with MS and supports them, regardless of their treatment, in measuring their personal disease progression and actively recognizing changes.
We are delighted that we have found an innovative partner in Temedica. We are convinced that together – and in cooperation with patients, treatment providers and scientists – we will make a valuable contribution to further deepen our disease understanding and to further improve the quality of life of patients.
Our collaboration with Temedica is creative, motivating, professional and at eye level. At Temedica, the users are in the focus and they are involved individually.
Ilio enables patients to record and measure their individual disease progression. The app interprets patients’health states, actively helps identify changes and long-term effects, and adjusts recommendations and exercises based on it.
AScalate Buddy is a trial companion app that trial participants use to enter their patient-generated study data.
Temedica is an innovative and knowledgeable digital health partner. We are delighted to work with them to develop a unique digital patient companion. We want to advance healthcare with patient-centered digital solutions to improve the standards of clinical practice.